Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (121-130 of 343) with videos related to

Pageof 35
Sort By:
Journal of Gastrointestinal Oncology|August 27, 2016
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtypeHumaid O Al-Shamsi, Deepa Anand, Rachna T Shroff, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 13, 2005
Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changesP Tripp, H K Malhotra, M Javle, et al.
JCO Precision Oncology|October 15, 2021
Adopting Consensus Terms for Testing in Precision MedicineNikki A Martin, Joel E Tepper, Veda N Giri, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Annals of Surgical Oncology|September 20, 2007
Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancerM M Javle, J F Gibbs, K K Iwata, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 15, 2015
Gallbladder cancer: expert consensus statementThomas A Aloia, Nicolas Járufe, Milind Javle, et al.
Molecular Oncology|January 5, 2016
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancerKjersti Tjensvoll, Morten Lapin, Tove Buhl, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|March 10, 2025
Neoadjuvant treatment for incidental gallbladder cancer: A systematic reviewPeeyush Varshney, Saphalta Baghmar, Bhawna Sirohi, et al.
Journal of Pain and Symptom Management|January 3, 2021
Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical TrialDavid Hui, Veronica Puac, Zeena Shelal, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemiaJane E Rogers, Jonathan D Mizrahi, Rachna T Shroff, et al.
Pageof 35

Showing results (121-130 of 343) with videos related to

Sort By:
Pageof 35
Journal of Gastrointestinal Oncology|August 27, 2016
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtypeHumaid O Al-Shamsi, Deepa Anand, Rachna T Shroff, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 13, 2005
Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changesP Tripp, H K Malhotra, M Javle, et al.
JCO Precision Oncology|October 15, 2021
Adopting Consensus Terms for Testing in Precision MedicineNikki A Martin, Joel E Tepper, Veda N Giri, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Annals of Surgical Oncology|September 20, 2007
Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancerM M Javle, J F Gibbs, K K Iwata, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 15, 2015
Gallbladder cancer: expert consensus statementThomas A Aloia, Nicolas Járufe, Milind Javle, et al.
Molecular Oncology|January 5, 2016
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancerKjersti Tjensvoll, Morten Lapin, Tove Buhl, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|March 10, 2025
Neoadjuvant treatment for incidental gallbladder cancer: A systematic reviewPeeyush Varshney, Saphalta Baghmar, Bhawna Sirohi, et al.
Journal of Pain and Symptom Management|January 3, 2021
Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical TrialDavid Hui, Veronica Puac, Zeena Shelal, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemiaJane E Rogers, Jonathan D Mizrahi, Rachna T Shroff, et al.
Pageof 35